Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
NASDAQ
$7.32
▼ DOWN 0.68% (-0.05)

KEY STATISTICS

Market Cap$2.04 B
52w High$9.42
52w Low$2.37
Dividend Yield—
Frequency—
P/E-38.53
Volume1.55M
Shares Out.145.10M

COMPANY

LEADERSHIP

Bernd Brust
CHIEF EXECUTIVE
Bernd Brust

COMPENSATION 2026

Salary$345,000
Stock Awards$2,603,552
Incentive Plan Pay$0
All Other Comp.$896,711
Total$3,845,263

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 20, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
415

PRICE TARGET

Target High$6.00
Target Low$6.00
Target Median$6.00
Target Consensus$6.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$43.64M
NOV
5
THU

PRICE

$7.32 ▼ DOWN 0.68% (−$0.05)
$7.27$7.35$7.429:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM7.32

About Maravai LifeSciences Holdings, Inc.

https://www.maravai.com ↗

Maravai LifeSciences provides products for biopharmaceutical development, diagnostics, and research, including nucleic acids and safety testing tools, serving biotech, pharma, and research institutions worldwide.

INDUSTRY

Biotechnology

A PRODUCT MARAVAI LIFESCIENCES HOLDINGS, INC. IS KNOWN FOR

CleanCap®
CleanCap®

CleanCap® is a novel mRNA capping technology that enhances the efficiency of mRNA translation. This technology is highly significant as it was a critical component in the world's first FDA-approved mRNA vaccine, developed by Pfizer and BioNTech.

COMPETITORS

COMPETITOR
ARCT COMPARE
BNTX COMPARE
MRNA COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q3-2025Q1-2026
Nucleic Acid Production Segment$28.75M $31.09M ▲$25.35M ▼$47.48M ▲
Biologics Safety Testing Segment$18.1M $16.31M ▼$16.28M ▼$18.36M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
North America$25.03M $27.44M ▲$35.69M ▲$31.28M ▼
EMEA$7.97M $7.68M ▼$21.95M ▲$10.45M ▼
Asia Pacific$8.34M $14.42M ▲$7.87M ▼$9.32M ▲
Latin And Central America$296K $324K ▲$329K ▲$386K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
109
LISTED HERE
19
RANKED BY POSITION SIZE
VTI
0.00% · 3.7M
XSU.TO
0.03% · 2.9M
SCHA
0.02% · 601.3K
KOMP
0.13% · 453.4K
DWAS
0.58% · 320.8K
DFAS
0.01% · 284.8K
DBXW.DE
0.01% · 148.4K
GNOM
0.59% · 75.0K
FSCC
0.15% · 73.6K
NIXT
0.88% · 51.4K
FHLC
0.01% · 51.3K
GINN
0.10% · 25.4K
MSGR
4.93% · 10.9K
FOHW.L
2.10% · 8.6K
BIB
0.04% · 5.3K
FESC
1.12% · 3.2K
AESL
0.23% · 628
USUE.DE
0.00% · 497
RESM
0.04% · 304

INSTITUTIONAL OWNERSHIP

SHARES OWNED
66.76%
HOLDERS
227
TOP 12 OF 227 · RANKED BY POSITION SIZE
Gtcr LLC
20.2M sh · $57.02M
12 West Capital Management LP
12.5M sh · $35.94M
Braidwell LP
10.2M sh · $28.98M
Blackrock Inc.
9.7M sh · $69.66M
Blackrock, Inc.
9.4M sh · $30.48M
Vanguard Group Inc
7.2M sh · $23.29M
Mackenzie Financial Corp
6.3M sh · $17.85M
T. Rowe Price Investment Management, Inc.
6.2M sh · $17.68M
Renaissance Technologies LLC
4.3M sh · $12.39M
Mirabella Financial Services Llp
3.8M sh · $10.76M
Monaco Asset Management Sam
3.7M sh · $10.49M
Tejara Capital Ltd
3.5M sh · $9.89M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Daniel Goldman
Daniel Goldman
Sale
2023-04-10

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Asarpota Rajesh
Sale · 5.5K shares
2026-08-31
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Brust Bernd
Sale · 29.3K shares
2026-08-10
★
OFFICER: CHIEF FINANCIAL OFFICER
Asarpota Rajesh
Sale · 5.5K shares
2026-07-30
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Brust Bernd
Sale · 29.3K shares
2026-07-08

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 1
1 GRADES IN THE LAST 12 MONTHS
Wells Fargo OVERWEIGHT

SECTORS PEERS

PEERPRICE
IOVA$8.69COMPARE
VIR$11.56COMPARE
TYRA$28.71COMPARE
SEPN$36.94COMPARE
BCAX$23.27COMPARE
REPL$15.04COMPARE
KURA$13.24COMPARE
PRME$3.72COMPARE